4893 items matching your search terms.

Association of dietary risks, behavioural and lifestyle factors, and the magnitude of disability burden among Australian cancer patients: An observational epidemiology study

Mahumud, R. A. Sultana, M. Gow, J. Rahman, M. A. Uddin, K. F. Kamal, M. Alam, K. Dawson, A. Law, C. K.
CANCER EPIDEMIOLOGY, 2022     DOI:10.1016/j.canep.2022.102161

The effectiveness of interventions on nutrition social behaviour change communication in improving child nutritional status within the first 1000 days: Evidence from a systematic review and meta-analysis

Mahumud, R. A. Uprety, S. Wali, N. Renzaho, A. M. N. Chitekwe, S.
MATERNAL AND CHILD NUTRITION, 2022     DOI:10.1111/mcn.13286

What matters for people with brain cancer? Selecting clinical quality indicators for an Australian Brain Cancer Registry

Matsuyama, M. Sachchithananthan, M. Leonard, R. Besser, M. Nowak, A. K. Truran, D. Vajdic, C. M. Zalcberg, J. R. Gan, H. K. Gedye, C. Varikatt, W. Koh, E. S. Kichenadasse, G. Sim, H. W. Gottardo, N. G. Spyridopoulos, D. Jeffree, R. L.
NEUROONCOL PRACT, 2022     DOI:10.1093/nop/npab055

Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease (CLARITY): statistical analysis plan for a randomised controlled Bayesian adaptive sample size trial

McGree, J. M. Hockham, C. Kotwal, S. Wilcox, A. Bassi, A. Pollock, C. Burrell, L. M. Snelling, T. Jha, V. Jardine, M. Jones, M. Clarity Trial Steering Committee
TRIALS, 2022     DOI:10.1186/s13063-022-06167-2

Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow up? Statistical analysis plan for the MEL-SELF randomised controlled trial

Medcalf, E. Taylor, A. Turner, R. Espinoza, D. Bell, K. J. L.
CONTEMPORARY CLINICAL TRIALS, 2022     DOI:10.1016/j.cct.2022.106761

The BLIiNG study - Breastfeeding length and intensity in gestational diabetes and metabolic effects in a subsequent pregnancy: A cohort study

Melov, S. J. White, L. Simmons, M. Kirby, A. Stulz, V. Padmanabhan, S. Alahakoon, T. I. Pasupathy, D. Cheung, N. W.
MIDWIFERY, 2022     DOI:10.1016/j.midw.2022.103262

Knowledge translation concerns for the CONSORT-PRO extension reporting guidance: a review of reviews

Mercieca-Bebber, R. Aiyegbusi, O. L. King, M. T. Brundage, M. Snyder, C. Calvert, M.
QUALITY OF LIFE RESEARCH, 2022     DOI:10.1007/s11136-022-03119-w

Patient-reported outcome (PRO) results from the AGITG DOCTOR trial: a randomised phase 2 trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinoma

Mercieca-Bebber, R. Barnes, E. H. Wilson, K. Samoon, Z. Walpole, E. Mai, T. Ackland, S. Burge, M. Dickie, G. Watson, D. Leung, J. Wang, T. Bohmer, R. Cameron, D. Simes, J. Gebski, V. Smithers, M. Thomas, J. Zalcberg, J. Barbour, A. P.
BMC CANCER, 2022     DOI:10.1186/s12885-022-09270-4

Patient-reported bowel, urinary and sexual outcomes after laparoscopic-assisted resection or open resection for rectal cancer: The Australasian Laparoscopic Cancer of the Rectum randomized clinical trial (ALaCart)

Mercieca-Bebber, R. Eggins, R. Brown, K. Gebski, V. J. Brewer, K. Lai, L. Bailey, L. Solomon, M. J. Lumley, J. W. Hewett, P. Clouston, A. D. Wilson, K. Hague, W. Hayes, J. White, S. Morgan, M. Simes, J. Stevenson, A. R. L.
ANNALS OF SURGERY, 2022     DOI:10.1097/SLA.0000000000005412

Barriers and facilitators to nurse-led advance care planning and palliative care practice change in primary healthcare: a qualitative study

Nagarajan, S. V. Lewis, V. Halcomb, E. Rhee, J. Morton, R. L. Mitchell, G. K. Tieman, J. Phillips, J. L. Detering, K. Gavin, J. Clayton, J. M.
AUSTRALIAN JOURNAL OF PRIMARY HEALTH, 2022     DOI:10.1071/PY21081

Using three scenarios to explain life expectancy in advanced cancer: attitudes of patients, family members, and other healthcare professionals

Nahm, S. H. Stockler, M. R. Martin, A. J. Grimison, P. Fox, P. Zielinski, R. Hawson, G. A. Tattersall, M. H. Kiely, B. E.
SUPPORTIVE CARE IN CANCER, 2022     DOI:10.1007/s00520-022-07167-3

Antiplatelet agents for chronic kidney disease

Natale, P. Palmer, S. C. Saglimbene, V. M. Ruospo, M. Razavian, M. Craig, J. C. Jardine, M. J. Webster, A. C. Strippoli, G. F.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022     DOI:10.1002/14651858.CD008834.pub4

The D-Health Trial: a randomised controlled trial of the effect of vitamin D on mortality

Neale, R. E. Baxter, C. Romero, B. D. McLeod, D. S. A. English, D. R. Armstrong, B. K. Ebeling, P. R. Hartel, G. Kimlin, M. G. O'Connell, R. van der Pols, J. C. Venn, A. J. Webb, P. M. Whiteman, D. C. Waterhouse, M.
LANCET DIABETES ENDOCRINOL, 2022     DOI:10.1016/S2213-8587(21)00345-4

SGLT2 inhibitors and finerenone: One or the other or both?

Neuen, B. L. Jardine, M. J.
NEPHROLOGY, DIALYSIS, TRANSPLANTATION, 2022     DOI:10.1093/ndt/gfac046

SGLT2 inhibitors may prevent diabetes

O'Hara, D. V. Jardine, M. J.
NAT REV NEPHROL, 2022     DOI:10.1038/s41581-022-00541-8